Omega Therapeutics, Inc. (OMGA) Misses Q2 EPS by 4c

Omega Therapeutics, Inc. (NASDAQ: OMGA) reported Q2 EPS of ($0.54), $0.04 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $760 thousand versus the consensus estimate of $378.57 thousand.

For earnings history and earnings-related data on Omega Therapeutics, Inc. (OMGA) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Accuray (ARAY) Tops Q4 EPS by 1c